Effects of miglitol versus sitagliptin on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus

Effects of miglitol versus sitagliptin on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus - Effects of miglitol versus sitagliptin on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009502

Enrollment

Registered

2012-12-07

Start date

2010-12-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

miglitol 150mg/day sitagliptin 50mg/day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c<9.4%

Exclusion criteria

Exclusion criteria: -diabetic coma within 6 month before -acute illness -pregnancy -renal dysfunction(creatinine: men>1.5mg/dL, women>1.3mg/dL) -recent insulin therapy -drug allergy -anemia(hemoglobin: men<11g/dL, women<10g/dL) -patient who disagree with this protocol

Design outcomes

Primary

Measure	Time frame
Change of the vlaues (glucose, insulin, glucagon, NEFA, triglyceride, Apolipoprotein B48, RLP-C) by cookie loading test at baseline and 10 weeks after each treatment.	—

Countries

Japan

Contacts

Public ContactKenta Okada

Jichi Medical University Endocrinology and Metabolism

kokada@jichi.ac.jp0285-58-7355

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026